Fingerprint
Dive into the research topics of 'Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C
Mark S. Sulkowski, Curtis Cooper, Bela Hunyady, Jidong Jia, Pavel Ogurtsov, Markus Peck-Radosavljevic, Mitchell L. Shiffman, Cihan Yurdaydin, Olav Dalgard
Research output: Contribution to journal › Review article › peer-review
111
Scopus
citations